"Designing Growth Strategies is in our DNA"

Mucopolysaccharidosis Treatment Market Size, Share & Industry Analysis, By Treatment (Enzyme Replacement Therapy (ERT), and Others), By Disease Type (Mucopolysaccharidosis Type I, Mucopolysaccharidosis Type II, Mucopolysaccharidosis Type IV A, Mucopolysaccharidosis Type VI, and Others), By Route of Administration (Intravenous, and Intracerebroventricular (ICV)), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2019-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI102551

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Key Mucopolysaccharidosis Types - by key regions (2018)
    2. Pipeline Analysis
    3. Key Industry Developments
    4. Regulatory Scenario- by Key Regions
    5. Overview of Emerging Treatments for Mucopolysaccharidosis
    6. Reimbursement Scenario - by Key Regions
  5. Global Mucopolysaccharidosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Treatment
      1. Enzyme Replacement Therapy (ERT)
      2. Others
    3. Market Analysis, Insights and Forecast – By Disease Type
      1. Mucopolysaccharidosis Type I
      2. Mucopolysaccharidosis Type II
      3. Mucopolysaccharidosis Type IV A
      4. Mucopolysaccharidosis Type VI
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous
      2. Intracerebroventricular (ICV)
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Specialty Clinics
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia pacific
      4. Rest of the World
  6. North America Mucopolysaccharidosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Enzyme Replacement Therapy (ERT)
      2. Others
    3. Market Analysis – By Disease Type
      1. Mucopolysaccharidosis Type I
      2. Mucopolysaccharidosis Type II
      3. Mucopolysaccharidosis Type IV A
      4. Mucopolysaccharidosis Type VI
      5. Others
    4. Market Analysis – By Route of Administration
      1. Intravenous
      2. Intracerebroventricular (ICV)
    5. Market Analysis – By End User
      1. Hospitals
      2. Specialty Clinics
      3. Others
    6. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Mucopolysaccharidosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Enzyme Replacement Therapy (ERT)
      2. Others
    3. Market Analysis – By Disease Type
      1. Mucopolysaccharidosis Type I
      2. Mucopolysaccharidosis Type II
      3. Mucopolysaccharidosis Type IV A
      4. Mucopolysaccharidosis Type VI
      5. Others
    4. Market Analysis – By Route of Administration
      1. Intravenous
      2. Intracerebroventricular (ICV)
    5. Market Analysis – By End User
      1. Hospitals
      2. Specialty Clinics
      3. Others
    6. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Mucopolysaccharidosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Enzyme Replacement Therapy (ERT)
      2. Others
    3. Market Analysis – By Disease Type
      1. Mucopolysaccharidosis Type I
      2. Mucopolysaccharidosis Type II
      3. Mucopolysaccharidosis Type IV A
      4. Mucopolysaccharidosis Type VI
      5. Others
    4. Market Analysis – By Route of Administration
      1. Intravenous
      2. Intracerebroventricular (ICV)
    5. Market Analysis – By End User
      1. Hospitals
      2. Specialty Clinics
      3. Others
    6. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. South Korea
      5. Rest of Asia Pacific
  9. Rest of the World Mucopolysaccharidosis Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Treatment
      1. Enzyme Replacement Therapy (ERT)
      2. Others
    3. Market Analysis – By Disease Type
      1. Mucopolysaccharidosis Type I
      2. Mucopolysaccharidosis Type II
      3. Mucopolysaccharidosis Type IV A
      4. Mucopolysaccharidosis Type VI
      5. Others
    4. Market Analysis – By Route of Administration
      1. Intravenous
      2. Intracerebroventricular (ICV)
    5. Market Analysis – By End User
      1. Hospitals
      2. Specialty Clinics
      3. Others
  10. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2017)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Shire (Takeda Pharmaceutical Company Limited)
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Denali Therapeutics
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. ArmaGen
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. REGENXBIO Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Sangamo Therapeutics
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. BioMarin
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Lysogene
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Abeona Therapeutics Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Ultragenyx Pharmaceutical
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Genzyme Corporation
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  11. Competitive Analysis
Read Less

Figure 1:  Global Mucopolysaccharidosis Treatment Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Mucopolysaccharidosis Treatment Market Value Share (%), by Treatment, 2018 & 2026

Figure 3:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Enzyme Replacement Therapy (ERT), 2015-2026

Figure 4:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 5:  Global Mucopolysaccharidosis Treatment Market Value Share (%), by Disease Type, 2018 & 2026

Figure 6:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Mucopolysaccharidosis Type I, 2015-2026

Figure 7:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Mucopolysaccharidosis Type II, 2015-2026

Figure 8:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Mucopolysaccharidosis Type IV A, 2015-2026

Figure 9:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Mucopolysaccharidosis Type VI, 2015-2026

Figure 10:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 11:  Global Mucopolysaccharidosis Treatment Market Value Share (%), by Route of Administration, 2018 & 2026

Figure 12:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Intravenous, 2015-2026

Figure 13:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Intracerebroventricular (ICV), 2015-2026

Figure 14:  Global Mucopolysaccharidosis Treatment Market Value Share (%), by End-user, 2018 & 2026

Figure 15:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Hospitals, 2015-2026

Figure 16:  Global Mucopolysaccharidosis Treatment Market Forecast (US$ Mn), by Specialty Clinics, 2015-2026

Figure 17:  Global Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Region, 2018 & 2026

Figure 18:  North America Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 19:  North America Mucopolysaccharidosis Treatment Market Value Share (%), by Treatment, 2018

Figure 20:  North America Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 21:  North America Mucopolysaccharidosis Treatment Market Value Share (%), by Disease Type, 2018

Figure 22:  North America Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 23:  North America Mucopolysaccharidosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 24:  North America Mucopolysaccharidosis Treatment Market Value (US$ Mn), by End-user, 2018 & 2026

Figure 25:  North America Mucopolysaccharidosis Treatment Market Value Share (%), by End-user, 2018

Figure 26:  North America Mucopolysaccharidosis Treatment Market Value (US$ Mn), By Country, 2018 & 2026

Figure 27:  North America Mucopolysaccharidosis Treatment Market Value Share (%), By Country, 2018

Figure 28:  Europe Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 29:  Europe Mucopolysaccharidosis Treatment Market Value Share (%), by Treatment, 2018

Figure 30:  Europe Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 31:  Europe Mucopolysaccharidosis Treatment Market Value Share (%), by Disease Type, 2018

Figure 32:  Europe Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 33:  Europe Mucopolysaccharidosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 34:  Europe Mucopolysaccharidosis Treatment Market Value (US$ Mn), by End-user, 2018 & 2026

Figure 35:  Europe Mucopolysaccharidosis Treatment Market Value Share (%), by End-user, 2018

Figure 36:  Europe Mucopolysaccharidosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 37:  Europe Mucopolysaccharidosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 38:  Asia Pacific Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 39:  Asia Pacific Mucopolysaccharidosis Treatment Market Value Share (%), by Treatment, 2018

Figure 40:  Asia Pacific Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 41:  Asia Pacific Mucopolysaccharidosis Treatment Market Value Share (%), by Disease Type, 2018

Figure 42:  Asia Pacific Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 43:  Asia Pacific Mucopolysaccharidosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 44:  Asia Pacific Mucopolysaccharidosis Treatment Market Value (US$ Mn), by End-user, 2018 & 2026

Figure 45:  Asia Pacific Mucopolysaccharidosis Treatment Market Value Share (%), by End-user, 2018

Figure 46:  Asia Pacific Mucopolysaccharidosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 47:  Asia Pacific Mucopolysaccharidosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 48:  Latin America Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 49:  Latin America Mucopolysaccharidosis Treatment Market Value Share (%), by Treatment, 2018

Figure 50:  Latin America Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 51:  Latin America Mucopolysaccharidosis Treatment Market Value Share (%), by Disease Type, 2018

Figure 52:  Latin America Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 53:  Latin America Mucopolysaccharidosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 54:  Latin America Mucopolysaccharidosis Treatment Market Value (US$ Mn), by End-user, 2018 & 2026

Figure 55:  Latin America Mucopolysaccharidosis Treatment Market Value Share (%), by End-user, 2018

Figure 56:  Latin America Mucopolysaccharidosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 57:  Latin America Mucopolysaccharidosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 58:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 59:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value Share (%), by Treatment, 2018

Figure 60:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 61:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value Share (%), by Disease Type, 2018

Figure 62:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 63:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value Share (%), by Route of Administration, 2018

Figure 64:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value (US$ Mn), by End-user, 2018 & 2026

Figure 65:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value Share (%), by End-user, 2018

Figure 66:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 67:  Middle East & Africa Mucopolysaccharidosis Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 68:  Global Mucopolysaccharidosis Treatment Market Share (%), By Company, 2018

Table 1:  Global Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 2:  Global Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015–2026

Table 3:  Global Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015–2026

Table 4:  Global Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by End-user, 2015–2026

Table 5:  Global Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 6:  North America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 7:  North America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 8:  North America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 9:  North America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026

Table 10:  North America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 11:  Europe Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 12:  Europe Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 13:  Europe Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 14:  Europe Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026

Table 15:  Europe Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 16:  Asia Pacific Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 17:  Asia Pacific Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 18:  Asia Pacific Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 19:  Asia Pacific Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026

Table 20:  Asia Pacific Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Latin America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 22:  Latin America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 23:  Latin America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 24:  Latin America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026

Table 25:  Latin America Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 26:  Middle East & Africa Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 27:  Middle East & Africa Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 28:  Middle East & Africa Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 29:  Middle East & Africa Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, by End-user, 2015-2026

Table 30:  Middle East & Africa Mucopolysaccharidosis Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Mucopolysaccharidosis Treatment Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?